BioSpace News Archive

A study out of China in 150 hospitalized patients conducted at 16 sites showed the medication did not help patients clear the virus better than standard care. It was also significantly more likely to cause serious side effects.

CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced that it will open a new laboratory in Hamburg, Germany ─ acquiring the former laboratory facilities and equipment of Provecs Medical GmbH, a company formerly active in cancer immunotherapy.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Dr. Mark Poznansky, Co-Creator of VaxCelerate, a self-assembling vaccine (SAV) platform, appeared as a guest on MSNBC’s All In with Chris Hayes last night to discuss COVID-19 vaccines and can be viewed from the following link

Xylyx Bio, a pioneer in advanced biological systems for drug development, today announced availability of products that recreate the lung environment in vitro to provide a predictive model that brings much-needed insight into the efficacy of COVID-19-related drug candidates.

Norwex today announced it will provide one million face masks to healthcare professionals fighting the spread of coronavirus on the frontlines around the world.

Today the Thailand Board of Investment announced that it has approved new economic measures to help mitigate the impact of the coronavirus.

DuPont launched a new program, #TyvekTogether, to increase the overall availability of Tyvek® personal protective garments in the company’s continued efforts to help combat the spread of COVID-19 and protect health care workers.

The Coronavirus outbreak has proven that healthcare institutions can no longer ignore the role of Artificial Intelligence (AI) in their daily workflow.

RemeGen today announced that the US Food and Drug Administration (FDA) granted Fast Track designation for RC18, a novel recombinant TACI-Fc (transmembrane activator and calcium modulator and cyclophilin ligand interactor) fusion protein, for the treatment of systemic lupus erythematosus (SLE).

Provider community needs virtual technology, clinical guidance and proven implementation strategies to combat coronavirus